McGrath et al., 1989 - Google Patents
GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage.McGrath et al., 1989
View PDF- Document ID
- 16702291756675564540
- Author
- McGrath M
- Hwang K
- Caldwell S
- Gaston I
- Luk K
- Wu P
- Ng V
- Crowe S
- Daniels J
- Marsh J
- Publication year
- Publication venue
- Proceedings of the National Academy of Sciences
External Links
Snippet
GLQ223 is a highly purified, formulated preparation of trichosanthin, a 26-kDa plant-derived ribosome-inactivating protein with potent inhibitory activity against human immunodeficiency virus (HIV) in vitro. The compound produced concentration-dependent inhibition of HIV …
- 210000004027 cells 0 title abstract description 119
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| McGrath et al. | GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage. | |
| Veronese et al. | Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene | |
| Lee-Huang et al. | MAP 30: a new inhibitor of HIV-1 infection and replication | |
| US4795739A (en) | Method of inhibiting HIV | |
| EP0318562B1 (en) | Method of selectively inhibiting hiv | |
| Watanabe et al. | Effect of recombinant soluble CD4 in rhesus monkeys infected with simian immunodeficiency virus of macaques | |
| Jackson et al. | Passive immunoneutralisation of human immunodeficiency virus in patients with advanced AIDS | |
| Furuta et al. | Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120. | |
| Wainberg et al. | Development of HIV-1 resistance to (−) 2′-deoxy-3′-thiacytidine in patients with AIDS or advanced AIDS-related complex | |
| Herbein et al. | HIV-1 induces tumour necrosis factor and IL-1 gene expression in primary human macrophages independent of productive infection | |
| JPH08504799A (en) | Therapeutic combination containing interferon | |
| TURANO et al. | Inhibitory effect of papaverine on HIV replication in vitro | |
| CA2168268C (en) | Aids and sle prophylactics | |
| CA2025634A1 (en) | Peptides including ctl epitopes of hiv proteins and use thereof | |
| Ramachandran et al. | Failure of short-term CD4-PE40 infusions to reduce virus load in human immunodeficiency virus-infected persons | |
| Fernández-Ortega et al. | Non-induced leukocyte extract reduces HIV replication and TNF secretion | |
| Siegel et al. | Human T-cell lymphotropic-I-associated leukemia/lymphoma | |
| KR19990044834A (en) | Negative Factor Inhibitor | |
| WU et al. | Apoptosis of HIV-infected cells following treatment with Sho-Saiko-to and its components | |
| WO1990009806A2 (en) | Composition for the inhibition of tumors and for the non-cytotoxic inhibition of replication of viruses | |
| Kuller et al. | Intrarectal inoculation of macaques by the simian immunodeficiency virus, SIVmne E11S: CD4+ depletion and AIDS | |
| Fernandez-Ortega et al. | Inhibition of in vitro HIV infection by dialysable leucocyte extracts | |
| RU2366697C2 (en) | Agent of systemic action, its application, pharmaceutical compositions, methods of treatment and prevention | |
| AU656574B2 (en) | Complexes of polyadenylic acid with polyuridylic acid | |
| Agy et al. | Viral and cellular gene expression in CD4+ human lymphoid cell lines infected by the simian immunodeficiency virus, SIV/Mne |